Search Results for "Pain"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pain. Results 631 to 640 of 874 total matches.

Treatment of Nerve Gas Poisoning

   
The Medical Letter on Drugs and Therapeutics • May 12, 1995  (Issue 948)
to a small amount of vapor within seconds causes miosis, rhinorrhea, ocular pain, conjunctivitis and dim ...
The recent attack in the Tokyo subway has led to many questions about the clinical effects, treatment and prevention of nerve gas poisoning.
Med Lett Drugs Ther. 1995 May 12;37(948):43-4 |  Show IntroductionHide Introduction

Corneal Surgery for Correction of Refractive Errors

   
The Medical Letter on Drugs and Therapeutics • Dec 17, 1999  (Issue 1068)
postoperative pain and occasional glare at night. Infection, astigmatism, which may be transient ...
All refractive corneal surgery reshapes the cornea to redirect light rays so that they focus on the retine....
Med Lett Drugs Ther. 1999 Dec 17;41(1068):122-3 |  Show IntroductionHide Introduction

Bivalirudin (Angiomax) For Angioplasty

   
The Medical Letter on Drugs and Therapeutics • Apr 30, 2001  (Issue 1103)
, bivalirudin can cause back pain, nausea, headache and hypotension. DOSAGE AND COST — The optimal dosage ...
Bivalirudin is being promoted as an intravenous (IV) anticoagulant that can be used instead of heparin in patients with unstable angina undergoing coronary angioplasty.
Med Lett Drugs Ther. 2001 Apr 30;43(1103):37-8 |  Show IntroductionHide Introduction

Alefacept (Amevive) For Treatment of Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Apr 14, 2003  (Issue 1154)
included pharyngitis, dizziness, increased cough, nausea, pruritus, myalgia, injection site pain ...
Alefacept (a le' fa sept; Amevive - Biogen) has been approved by the FDA for parenteral treatment of adults with moderate to severe chronic plaque psoriasis.
Med Lett Drugs Ther. 2003 Apr 14;45(1154):31-2 |  Show IntroductionHide Introduction

Minimal Surgery for Treatment of GERD

   
The Medical Letter on Drugs and Therapeutics • Sep 01, 2003  (Issue 1164)
. SURGICAL THERAPY — GERD symptoms such as heartburn, regurgitation, dysphagia and chest pain improve ...
Laparoscopic surgery has become increasingly popular for the treatment of gastroesophageal reflux disease (GERD). The usual surgical procedure, a Nissen fundoplication, prevents reflux into the esophagus. The review compares medical treatment with a proton pump inhibitor vs. surgical therapy as well as open vs. the new laparoscopic technique. Morbidity and mortality with the procedures are discussed.
Med Lett Drugs Ther. 2003 Sep 1;45(1164):69-70 |  Show IntroductionHide Introduction

Tattoo Removal

   
The Medical Letter on Drugs and Therapeutics • Nov 24, 2003  (Issue 1170)
of green ink. ADVERSE EFFECTS — Tattoo removal with Q-switched lasers is moderately painful; a local ...
While more people than ever are getting tattoos, many come to regret their decision and would like to have them removed. The technology of removing tattoos is much better than it used to be, but still far from perfect. Complete removal of all pigments with restoration of normal skin color and texture is not always possible (M Kuperman-Beade et al, Am J Clin Dermatol 2001; 2:21; GM Lipper and RR Anderson in IM Freedberg et al, eds, Fitzpatrick's Dermatology in General Medicine 6th ed, New York:McGraw-Hill 2003, page 2508).
Med Lett Drugs Ther. 2003 Nov 24;45(1170):95-6 |  Show IntroductionHide Introduction

Do NSAIDs Interfere with the Cardioprotective Effects of Aspirin?

   
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004  (Issue 1188)
on these reports by advertising that aspirintaking patients who need pain relief should use acetaminophen instead ...
Low-dose aspirin is widely used as an antiplatelet drug to reduce the risk of cardiovascular disease (Medical Letter 2000; 42:18). Recent reports suggest that the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (Motrin, and others) may decrease the efficacy of aspirin for this indication. The manufacturer of Tylenol is capitalizing on these reports by advertising that aspirin-taking patients who need pain relief should use acetaminophen instead of ibuprofen.
Med Lett Drugs Ther. 2004 Aug 2;46(1188):61-2 |  Show IntroductionHide Introduction

Vagus Nerve Stimulation for Depression

   
The Medical Letter on Drugs and Therapeutics • Jun 20, 2005  (Issue 1211)
implantation can cause pain at the site of the device. Infection has occurred, according to the manufacturer ...
A device that stimulates the vagus nerve was approved by the FDA in July 1997 for treatment of refractory epilepsy and is now considered "approvable" for treatment-resistant depression.
Med Lett Drugs Ther. 2005 Jun 20;47(1211):50 |  Show IntroductionHide Introduction

Deferasirox (Exjade): A New Iron Chelator

   
The Medical Letter on Drugs and Therapeutics • Apr 24, 2006  (Issue 1233)
include abdominal pain, nausea, vomiting, diarrhea and rash. Hearing loss and ocular disturbances ...
Deferasirox (Exjade - Novartis), an oral chelating agent, recently received accelerated approval from the FDA as an orphan drug for oral treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients >2 years old. Deferasirox is a tridentate (2 molecules of deferasirox bind to one atom of iron) chelating agent with high affinity for iron. It has much lower affinity for zinc and copper.
Med Lett Drugs Ther. 2006 Apr 24;48(1233):35-6 |  Show IntroductionHide Introduction

In Brief: Herpes Zoster Vaccine (Zostavax) Revisited

   
The Medical Letter on Drugs and Therapeutics • May 31, 2010  (Issue 1339)
recipients and in 0.04% of patients who received a placebo injection. Erythema, swelling, pain ...
The 2006 Medical Letter article on the then-new varicella-zoster vaccine concluded that Zostavax appears to be safe and effective in protecting patients ≥60 years old against herpes zoster and postherpetic neuralgia, especially in reducing the severity and duration of the disease.1 Some new information has recently become available.CLINICAL STUDIES — A Veterans Administration randomized, double-blind trial enrolled more than 38,000 patients ≥60 years old and followed them for a mean of 3.4 years after administration of Zostavax or placebo. Since the efficacy of the vaccine had been...
Med Lett Drugs Ther. 2010 May 31;52(1339):41 |  Show IntroductionHide Introduction